Europe Smart Inhalers Market 2022-2027

    Multi User License - $2,500

    In Stock

    Coming Soon




    Smart inhalers are becoming more popular as a means of managing and treating respiratory illnesses. A growing number of companies are using digital technologies into their products to improve asthma and chronic obstructive pulmonary disease (COPD) management, as well as pharmaceutical effectiveness.


    A handful of products are already on the market, and several more are expected to get regulatory approval and join the market in the coming years. New smart inhalers’ could improve treatment options and help scientists figure out what’s causing the global epidemic.


    infographic: Europe Smart Inhalers Market, Europe Smart Inhalers Market Size, Europe Smart Inhalers Market Trends, Europe Smart Inhalers Market Forecast, Europe Smart Inhalers Market Risks, Europe Smart Inhalers Market Report, Europe Smart Inhalers Market Share



    The Europe Smart Inhalers Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.



    FindAir, a respiratory health startup established in Poland, will start selling its digital inhaler add-on to European customers. The FindAir One device connects wirelessly to a companion mobile and web app for both patients and clinicians. For the former, the app captures data passively with each usage to track the frequency of a user’s symptoms, as well as other pertinent data like pollen level, air quality, and whether any overlaps exist. Physicians, on the other hand, can look at the data to see how the user is doing when they are away from the office.


    The Smart Inhaler from Adherium Ltd has been selected for the myAirCoach programme, which is part of the European Union’s Horizon Framework for Research and Innovation.


    Novartis has received European Commission approval for Enerzair Breezhaler, which includes the first digital companion (sensor and app) that may be prescribed alongside an asthma therapy in the EU. Enerzair Breezhaler, a once-daily LABA/long-acting muscarinic antagonist (LAMA)/ICS fixed-dose combination, is the first LABA/LAMA/ICS fixed-dose combination available in the EU for these patients.





    1. What is the average cost per Europe Smart Inhalers Market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a Smart Inhalers Market in Europe?
    3. How many Europe Smart Inhalers Market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a Europe Smart Inhalers Market and key vendor selection criteria
    6. Where is the Europe Smart Inhalers Market manufactured? What is the average margin per equipment?
    7. Market share of Europe Smart Inhalers Market manufacturers and their upcoming products
    8. The most important planned Europe Smart Inhalers Market in next 2 years
    9. Details on network of major Europe Smart Inhalers Market and pricing plans
    10. Cost advantage for OEMs who manufacture Europe Smart Inhalers Market in-house
    11. 5 key predictions for next 5 years in Europe Smart Inhalers Market
    12. Average B-2-B Europe Smart Inhalers Market price in all segments
    13. Latest trends in Europe Smart Inhalers Market, by every market segment
    14. The market size (both volume and value) of Europe Smart Inhalers Market in 2022-2027 and every year in between?
    15. Global production breakup of Europe Smart Inhalers Market, by suppliers and their OEM relationship
    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in theIndustry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2027
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2027
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix


      Your Cart
      Your cart is emptyReturn to Shop